ArticleHeliyon2021

Co-administration of berberine/gypenosides/bifendate ameliorates metabolic disturbance but not memory impairment in type 2 diabetic mice.

Meng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.